drugset / Trial / NCT02195453
Chemotherapy Combined With Yangzhengxiaoji Capsule in Patients With Advanced Non-Small Cell Lung Cancer
Phase 4
Unknown
520 enrolled
Shandong Cancer Hospital and Institute
Peking University Cancer Hospital & Institute · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to observe quality of life and treatment side effects in patients with advanced non small cell lung cancer (NSCLC) receive chemotherapy and Yangzhengxiaoji capsule.
Timeline
- Start
- 2014-08
- Primary completion
- 2016-09
- Completion
- 2016-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Yangzhengxiaoji | Traditional medicine (herbal / TCM) | — | Oral |
| Background | Cisplatin | Other / unclassified | 75 mg/m2 | Intravenous |
| Background | Gemcitabine | Small molecule | 1000 mg/m2 | Intravenous |
| Background | Pemetrexed | Small molecule | 500 mg/m2 | Intravenous |